Pinnacle Advisory Group’s VanEck Biotech ETF BBH Stock Holding History

Pinnacle Advisory Group’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-124,779	Closed	-$20.2M	–	182
2020 Q3	$20.2M	Buy	124,779 +5,898	+5%	+$959K	1.34%	26
2020 Q2	$19.4M	Buy	118,881 +116,344	+4,586%	+$17.7M	1.35%	25
2020 Q1	$325K	Buy	2,537 +623	+33%	+$83.9K	0.03%	126
2019 Q4	$267K	Buy	+1,914	New	+$252K	0.02%	145

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Pinnacle Advisory Group's BBH Position: Q4 2020 in Review

Pinnacle Advisory Group sold out of VanEck Biotech ETF (BBH) in Q4 2020, closing a stake of 124,779 shares — an estimated $20.2M sold.

Pinnacle Advisory Group first reported a position in BBH in Q4 2019 and held it in 4 quarters. The position peaked at $20.2M in Q3 2020. 108 funds tracked by Wall St. Rank hold BBH as of Q4 2020.

Pinnacle Advisory Group reported no remaining VanEck Biotech ETF position as of Q4 2020 after selling out during the quarter.
Pinnacle Advisory Group sold 124,779 VanEck Biotech ETF shares in Q4 2020, an estimated $20.2M.
Pinnacle Advisory Group first reported a position in VanEck Biotech ETF in Q4 2019 and held it in 4 quarters.
Pinnacle Advisory Group's VanEck Biotech ETF position peaked at $20.2M in Q3 2020.
108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2020.

Based on Pinnacle Advisory Group's 13F filing for Q4 2020, filed 9 Feb 2021.